Therapeutics Inc.
Mark Deers is an experienced biostatistician currently serving as Principal Biostatistician at Therapeutics Inc. since February 2023. With a robust background in the field, Mark previously held the position of Senior Biostatistician II at Allucent from June 2020 to December 2022 and worked as a Senior Biostatistician at Accenture for several years. Mark's career includes roles such as Senior Biostatistician at CYTEL STATISTICAL SOFTWARE & SERVICES and Accenture, as well as Assistant Vice President, Senior Credit Risk Analyst at M&T Bank. Academic credentials include a Master's degree in Statistics and a Bachelor's degree in Mathematics, both obtained from the University at Buffalo.
This person is not in any offices
Therapeutics Inc.
Therapeutics Inc. is a drug research and development company focusing on integration of clinical and regulatory strategies, trial design, product development, and marketplace analysis. The company’s services include clinical development project management, medical monitoring, and non-clinical development such as designing and managing pharmacology and toxicology programs. Therapeutics develops drugs and devices for acne, psoriasis, melasma, excess facial hair, injectable fillers, photoaging, and onychomycosis. The company was founded in 1997 and is headquartered in San Diego, California.